Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1/2 1

Status

Withdrawn 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Breast Neoplasms 5Stomatitis 3Head and Neck Neoplasms 3Fatigue 3Colorectal Neoplasms 3Pain 2Multiple Myeloma 2Lung Neoplasms 2Carcinoma, Hepatocellular 2Ulcer 1Trauma, Nervous System 1Spondylitis, Ankylosing 1Skin Neoplasms 1Schwannomatosis 1Rectal Neoplasms 1Psoriasis 1Pleural Effusion, Malignant 1Pancreatic Cyst 1Ovarian Neoplasms 1Non-functioning Pituitary Adenoma 1Neurofibromatosis 1 1Neurilemmoma 1Neoplasms 1Myelodysplastic Syndromes 1Metastatic Non-Squamous Non-Small Cell Lung Cancer 1Mesothelioma 1Malignant Neoplasm of Colorectum 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Lymphoma 1

Interventions

Cyclophosphamide 155Rituximab 148Etoposide 84fludarabine phosphate 73Peripheral Blood Stem Cell Transplantation 68Mycophenolic Acid 63Busulfan 62Filgrastim 59Melphalan 58Tacrolimus 54Whole-Body Irradiation 51Cytarabine 46fludarabine 45Radiotherapy 43Methotrexate 41Granulocyte Colony-Stimulating Factor 41Cyclosporine 41Vincristine 35Antilymphocyte Serum 35Carmustine 33Doxorubicin 29Prednisone 26Thiotepa 25Bendamustine Hydrochloride 24Methylprednisolone 22Ifosfamide 22Dexamethasone 22thymoglobulin 21sargramostim 20plerixafor 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Lymphoma, Non-Hodgkin × Saline Solution × Clear all
NCT00570999 2012-05-10

KGF Haplo Allo

European Society for Blood and Marrow Transplantation

Phase 2 Withdrawn
LymphoidMyeloidOther hematologic neoplasm

Hodgkin Disease, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡